Benserazide 12.5 mg / L-DOPA 50 mg Extended Release Oral Capsule
RxNorm 411820
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 411820 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Benserazide 12.5 mg / L-DOPA 50 mg Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Benserazide 12.5 mg / levodopa 50 mg Extended Release Oral Capsule
(Atom ID: 12349165)
SY